FL CARES: Cancer Drug Property Dataset

Avapritinib US FDA Label

Compound: (1S)-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamine
Description: NA

Brand Name:
Code(s): BLU285
Approved:
Kinase Class: RY
Inhibitor Type: I/I
Literature (PubMed): 0
Target(s): KIT proto-oncogene, receptor tyrosine kinase , Platelet derived growth factor receptor alpha , Platelet derived growth factor receptor beta
Disease(s): gastrointestinal stromal tumor , systemic mastocytosis

International Nonproprietary Name: Avapritinib [INN] (Source: PubChem)

KEGG Drug ID: D11279 (Source: PubChem)

SureChEMBL ID: SCHEMBL16652297 (Source: PubChem)

USFDA Precision ID: UNII-513P80B4YJ (Source: PubChem)

US Adopted Name: AVAPRITINIB [USAN] (Source: PubChem)

Sources: PubChem (5)